Triethylenethiophosphoramide in treatment of metastatic cerebral malignancy.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003919:Diabetes Insipidus / Q000175:diagnosis*; D020790:Diabetes Insipidus, Neurogenic; D003937:Diagnosis, Differential; D006801:Humans; D009369:Neoplasms; D010190:Pancreatic Neoplasms; D010902:Pituitary Gland; D010911:Pituitary Neoplasms; D013852:Thiotepa
D000970:Antineoplastic Agents; D013852:Thiotepa
CYTOTOXIC DRUGS/therapeutic use; DIABETES INSIPIDUS/differential diagnosis; PANCREAS/neoplasms; PITUITARY GLAND/neoplasms